Literature DB >> 16142239

Interaction between conventional dendritic cells and natural killer cells is integral to the activation of effective antiviral immunity.

Christopher E Andoniou1, Serani L H van Dommelen, Valentina Voigt, Daniel M Andrews, Geraldine Brizard, Carine Asselin-Paturel, Thomas Delale, Katryn J Stacey, Giorgio Trinchieri, Mariapia A Degli-Esposti.   

Abstract

Dendritic cells (DCs) regulate various aspects of innate immunity, including natural killer (NK) cell function. Here we define the mechanisms involved in DC-NK cell interactions during viral infection. NK cells were efficiently activated by murine cytomegalovirus (MCMV)-infected CD11b(+) DCs. NK cell cytotoxicity required interferon-alpha and interactions between the NKG2D activating receptor and NKG2D ligand, whereas the production of interferon-gamma by NK cells relied mainly on DC-derived interleukin 18. Although Toll-like receptor 9 contributes to antiviral immunity, we found that signaling pathways independent of Toll-like receptor 9 were important in generating immune responses to MCMV, including the production of interferon-alpha and the induction of NK cell cytotoxicity. Notably, adoptive transfer of MCMV-activated CD11b(+) DCs resulted in improved control of MCMV infection, indicating that these cells participate in controlling viral replication in vivo.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16142239     DOI: 10.1038/ni1244

Source DB:  PubMed          Journal:  Nat Immunol        ISSN: 1529-2908            Impact factor:   25.606


  132 in total

1.  Flt3 permits survival during infection by rendering dendritic cells competent to activate NK cells.

Authors:  Céline Eidenschenk; Karine Crozat; Philippe Krebs; Ramon Arens; Daniel Popkin; Carrie N Arnold; Amanda L Blasius; Chris A Benedict; Eva Marie Y Moresco; Yu Xia; Bruce Beutler
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-10       Impact factor: 11.205

Review 2.  Effect of NKG2D ligand expression on host immune responses.

Authors:  Marine Champsaur; Lewis L Lanier
Journal:  Immunol Rev       Date:  2010-05       Impact factor: 12.988

Review 3.  Evasion of natural killer cells by influenza virus.

Authors:  Hailong Guo; Pawan Kumar; Subramaniam Malarkannan
Journal:  J Leukoc Biol       Date:  2010-08-03       Impact factor: 4.962

Review 4.  Modulation of host innate and adaptive immune defenses by cytomegalovirus: timing is everything.

Authors:  A Loewendorf; C A Benedict
Journal:  J Intern Med       Date:  2010-05       Impact factor: 8.989

5.  Homeostatic control of conjunctival mucosal goblet cells by NKT-derived IL-13.

Authors:  C S De Paiva; J K Raince; A J McClellan; K P Shanmugam; S B Pangelinan; E A Volpe; R M Corrales; W J Farley; D B Corry; D-Q Li; S C Pflugfelder
Journal:  Mucosal Immunol       Date:  2010-12-22       Impact factor: 7.313

6.  NKG2D is required for NK cell activation and function in response to E1-deleted adenovirus.

Authors:  Jiangao Zhu; Xiaopei Huang; Yiping Yang
Journal:  J Immunol       Date:  2010-11-12       Impact factor: 5.422

Review 7.  Boosting vaccine efficacy the natural (killer) way.

Authors:  Carolyn E Rydyznski; Stephen N Waggoner
Journal:  Trends Immunol       Date:  2015-08-10       Impact factor: 16.687

8.  Rickettsiae stimulate dendritic cells through toll-like receptor 4, leading to enhanced NK cell activation in vivo.

Authors:  Jeffrey M Jordan; Michael E Woods; Lynn Soong; David H Walker
Journal:  J Infect Dis       Date:  2009-01-15       Impact factor: 5.226

9.  NKG2D Regulation of Lung Pathology and Dendritic Cell Function Following Respiratory Syncytial Virus Infection.

Authors:  Huan Liu; Andrew R Osterburg; Jennifer Flury; Shuo Huang; Francis X McCormack; Stephania A Cormier; Michael T Borchers
Journal:  J Infect Dis       Date:  2018-10-20       Impact factor: 5.226

10.  Dendritic cell-mediated NK cell activation is controlled by Jagged2-Notch interaction.

Authors:  Mika Kijima; Takeshi Yamaguchi; Chieko Ishifune; Yoichi Maekawa; Akemi Koyanagi; Hideo Yagita; Shigeru Chiba; Kenji Kishihara; Mitsuo Shimada; Koji Yasutomo
Journal:  Proc Natl Acad Sci U S A       Date:  2008-05-05       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.